相似文献
1
Visceral perception: inflammatory and non-inflammatory mediators.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i19-23. doi: 10.1136/gut.51.suppl_1.i19.
2
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i67-71. doi: 10.1136/gut.51.suppl_1.i67.
3
Hypersensitivity in functional gastrointestinal disorders.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i25-8. doi: 10.1136/gut.51.suppl_1.i25.
4
Visceral hypersensitivity.
J Clin Gastroenterol. 2005 May-Jun;39(5 Suppl 3):S194-203; discussion S210. doi: 10.1097/01.mcg.0000156114.22598.1b.
5
Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i29-33. doi: 10.1136/gut.51.suppl_1.i29.
6
Effects of inflammatory mediators on gut sensitivity.
Can J Gastroenterol. 1999 Mar;13 Suppl A:42A-46A. doi: 10.1155/1999/846809.
7
[The role of vagal afferents in visceral hyperalgesia].
Folia Med Cracov. 2005;46(3-4):97-105.
8
Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i34-40. doi: 10.1136/gut.51.suppl_1.i34.
9
Sensation and gas dynamics in functional gastrointestinal disorders.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i72-5. doi: 10.1136/gut.51.suppl_1.i72.
10
Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.
Pain. 2014 Oct;155(10):1962-75. doi: 10.1016/j.pain.2014.06.015. Epub 2014 Jun 24.
引用本文的文献
1
GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release.
Pain. 2025 Mar 1;166(3):596-613. doi: 10.1097/j.pain.0000000000003399. Epub 2024 Oct 3.
2
Polyphenols and extracts from (Roxb.) Roscoe leaf mitigate pain, inflammation and pyrexia by inhibiting cyclooxygenase-2: an and studies.
Front Pharmacol. 2024 Feb 14;15:1344123. doi: 10.3389/fphar.2024.1344123. eCollection 2024.
3
Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.
Front Pharmacol. 2022 May 9;13:778032. doi: 10.3389/fphar.2022.778032. eCollection 2022.
4
Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role.
Cureus. 2022 Apr 18;14(4):e24240. doi: 10.7759/cureus.24240. eCollection 2022 Apr.
5
Non-pharmacological management of pediatric functional abdominal pain disorders: Current evidence and future perspectives.
World J Clin Pediatr. 2022 Mar 9;11(2):105-119. doi: 10.5409/wjcp.v11.i2.105.
6
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders.
Int J Mol Sci. 2021 Sep 20;22(18):10134. doi: 10.3390/ijms221810134.
7
Ulinastatin Exhibits Antinociception in Rat Models of Acute Somatic and Visceral Pain Through Inhibiting the Local and Central Inflammation.
J Pain Res. 2021 May 4;14:1201-1214. doi: 10.2147/JPR.S303595. eCollection 2021.
8
Supraspinal Mechanisms of Intestinal Hypersensitivity.
Cell Mol Neurobiol. 2022 Mar;42(2):389-417. doi: 10.1007/s10571-020-00967-3. Epub 2020 Oct 8.
9
Co-administration of Pregabalin and Curcumin Synergistically Decreases Pain-Like Behaviors in Acute Nociceptive Pain Murine Models.
Molecules. 2020 Sep 11;25(18):4172. doi: 10.3390/molecules25184172.
10
Effects and mechanisms of acupuncture and electroacupuncture for functional dyspepsia: A systematic review.
World J Gastroenterol. 2020 May 21;26(19):2440-2457. doi: 10.3748/wjg.v26.i19.2440.
本文引用的文献
1
Chronic low-level administration of diquat increases the nociceptive response to gastric distension in rats: role of mast cells and tachykinin receptor activation.
Pain. 2001 May;92(1-2):219-27. doi: 10.1016/s0304-3959(01)00257-3.
2
Effect of ovarian hormones on intestinal mast cell reactivity to substance P.
Life Sci. 2001 Jan 19;68(9):1047-56. doi: 10.1016/s0024-3205(00)01008-0.
3
Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve.
Am J Physiol Gastrointest Liver Physiol. 2000 Oct;279(4):G781-90. doi: 10.1152/ajpgi.2000.279.4.G781.
4
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways.
Am J Respir Crit Care Med. 2000 May;161(5):1672-80. doi: 10.1164/ajrccm.161.5.9907133.
5
Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.
Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G670-6. doi: 10.1152/ajpgi.2000.278.5.G670.
6
Role of kinin B1 and B2 receptors and mast cells in post intestinal infection-induced hypersensitivity to distension.
Neurogastroenterol Motil. 1998 Dec;10(6):499-508. doi: 10.1046/j.1365-2982.1998.00123.x.
7
Intracolonic glycerol induces abdominal contractions in rats: role of 5-HT3 receptors.
Fundam Clin Pharmacol. 1998;12(6):619-23. doi: 10.1111/j.1472-8206.1998.tb00995.x.
8
Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT.
Dig Dis Sci. 1998 Apr;43(4):727-37. doi: 10.1023/a:1018853728251.
9
Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells.
Neurogastroenterol Motil. 1997 Dec;9(4):271-9. doi: 10.1046/j.1365-2982.1997.d01-63.x.
10
Effects of nematode infection on sensitivity to intestinal distension: role of tachykinin NK2 receptors.
Eur J Pharmacol. 1997 Oct 22;337(2-3):279-82. doi: 10.1016/s0014-2999(97)01275-2.
Zotero 插件